Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryoichi Nakazawa

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Clinical Calcium|December 4, 2004
[Optimum calcium concentration in the dialysate]Ryoichi Nakazawa
Clinical Calcium|December 4, 2004
[The K/DOQI guidelines on diagnosis and treatment of aluminum bone disease in hemodialysis patients]Ryoichi Nakazawa
Cureus|April 30, 2025
Combination Treatment With Intravenous and Oral Calcimimetics for Secondary Hyperparathyroidism in Hemodialysis Patients Who Decline ParathyroidectomyRyoichi Nakazawa, Akira Onozaki, Kazuhiro Akiyama, et al.
Cureus|January 21, 2026
Multiple Occult Fractures at Hemodialysis Initiation in a Chronic Kidney Disease Patient: Diagnostic Value of MRI and Potential Role of Zinc DeficiencyRyoichi Nakazawa, Akira Onozaki, Takashi Uchino, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 15, 2010
A novel bioactive haemodialysis system using dissolved dihydrogen (H2) produced by water electrolysis: a clinical trialMasaaki Nakayama, Hirofumi Nakano, Hiromi Hamada, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|February 7, 2014
Randomized pilot trial between prostaglandin I2 analog and anti-platelet drugs on peripheral arterial disease in hemodialysis patientsTakayasu Ohtake, Motoyoshi Sato, Ryoichi Nakazawa, et al.
Scientific Reports|January 12, 2018
Novel haemodialysis (HD) treatment employing molecular hydrogen (H<sub>2</sub>)-enriched dialysis solution improves prognosis of chronic dialysis patients: A prospective observational studyMasaaki Nakayama, Noritomo Itami, Hodaka Suzuki, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|November 27, 2013
Effect of a hydrogen (H2)-enriched solution on the albumin redox of hemodialysis patientsHiroyuki Terawaki, Wan-Jun Zhu, Yukie Matsuyama, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|March 25, 2006
Low-density lipoprotein apheresis therapy with a direct hemoperfusion column: a Japanese multicenter clinical trialHiromi Tasaki, Kazuhito Yamashita, Yasushi Saito, et al.
Artificial Organs|April 16, 2004
Arresting dialysis-related amyloidosis: a prospective multicenter controlled trial of direct hemoperfusion with a beta2-microglobulin adsorption columnFumitake Gejyo, Yoshindo Kawaguchi, Shigeko Hara, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Clinical Calcium|December 4, 2004
[Optimum calcium concentration in the dialysate]Ryoichi Nakazawa
Clinical Calcium|December 4, 2004
[The K/DOQI guidelines on diagnosis and treatment of aluminum bone disease in hemodialysis patients]Ryoichi Nakazawa
Cureus|April 30, 2025
Combination Treatment With Intravenous and Oral Calcimimetics for Secondary Hyperparathyroidism in Hemodialysis Patients Who Decline ParathyroidectomyRyoichi Nakazawa, Akira Onozaki, Kazuhiro Akiyama, et al.
Cureus|January 21, 2026
Multiple Occult Fractures at Hemodialysis Initiation in a Chronic Kidney Disease Patient: Diagnostic Value of MRI and Potential Role of Zinc DeficiencyRyoichi Nakazawa, Akira Onozaki, Takashi Uchino, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 15, 2010
A novel bioactive haemodialysis system using dissolved dihydrogen (H2) produced by water electrolysis: a clinical trialMasaaki Nakayama, Hirofumi Nakano, Hiromi Hamada, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|February 7, 2014
Randomized pilot trial between prostaglandin I2 analog and anti-platelet drugs on peripheral arterial disease in hemodialysis patientsTakayasu Ohtake, Motoyoshi Sato, Ryoichi Nakazawa, et al.
Scientific Reports|January 12, 2018
Novel haemodialysis (HD) treatment employing molecular hydrogen (H<sub>2</sub>)-enriched dialysis solution improves prognosis of chronic dialysis patients: A prospective observational studyMasaaki Nakayama, Noritomo Itami, Hodaka Suzuki, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|November 27, 2013
Effect of a hydrogen (H2)-enriched solution on the albumin redox of hemodialysis patientsHiroyuki Terawaki, Wan-Jun Zhu, Yukie Matsuyama, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|March 25, 2006
Low-density lipoprotein apheresis therapy with a direct hemoperfusion column: a Japanese multicenter clinical trialHiromi Tasaki, Kazuhito Yamashita, Yasushi Saito, et al.
Artificial Organs|April 16, 2004
Arresting dialysis-related amyloidosis: a prospective multicenter controlled trial of direct hemoperfusion with a beta2-microglobulin adsorption columnFumitake Gejyo, Yoshindo Kawaguchi, Shigeko Hara, et al.
Pageof 2